PPD Enhances Central Lab Data Capabilities via Preclarus®
News Feb 12, 2016

Pharmaceutical Product Development, LLC (PPD) is expanding Preclarus®, to include a comprehensive set of data solutions that supports the company’s central lab operations. These changes will enable study sites to access clean central lab data in real time, improve inventory management and order tracking, facilitate patient management and safety, and establish complete chain of custody for samples. The goal of these enhancements is to increase the efficiency and effectiveness of managing central lab data for PPD’s clients.
With the expansion of the Preclarus brand, PPD® Laboratories is introducing the new Preclarus investigator site portal to support clinical trial sites. This portal is a key enhancement for PPD Laboratories’ clients because it builds upon the company’s current capabilities to provide sites with new tools and options to access clinical trial data and help better manage their patients. The company’s newly named Preclarus central lab database will continue to support the company’s central lab operations and project teams with real-time, study wide lab results, project status and site metrics.
“Preclarus offers our clients an unprecedented view of central laboratory data that support their clinical trials,” explains David Johnston, Ph.D., executive vice president of PPD Laboratories. “With its real-time access to study details, patient data and laboratory results, Preclarus drives informed decision-making and increased efficiency for PPD Laboratories and its clients.”
Preclarus is PPD’s comprehensive data solution that consolidates and standardizes data from multiple sources to give PPD teams and clients transparent, real-time access to clinical trial operations and patient data, which can be visualized on interactive dashboards. Coupled with sophisticated analytics that enable innovative research approaches, Preclarus provides the transparent reporting and analytic capabilities needed to turn data into actionable intelligence.
The new central lab portal is designed to make it easier for investigational sites to support PPD clinical trials. The reports and tools within the Preclarus investigator site portal simplify every process, including adding patients to the trial, ordering sample collection kits, reviewing laboratory results, managing patients and critical values, and accessioning and shipping samples to PPD. The new portal also provides on-site biorepository tools to help clients manage samples at their site and track them to their final destinations.
PPD Laboratories combines world-class scientific expertise with state-of-the art technologies supported by a commitment to exceptional quality. From early development through late stage research, clients benefit from comprehensive lab services spanning bioanalytical, vaccine sciences, GMP, central lab testing and biomarkers.
RELATED ARTICLES
PhoreMost and Plexxikon Collaborate to Identify Novel Drug Targets
NewsPhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has signed a collaborative agreement with Plexxikon Inc., the small molecule structure-guided R&D centre of Daiichi Sankyo.
READ MOREAnti-Malaria Drugs Delivered With Caffeine
NewsMany drug delivery systems, such as capsules and tablets, can be difficult to swallow, especially for children. Making delivery systems out of polymer gels is an attractive option, but usually requires hazardous levels of heavy metals to be used. Now, scientists have found a way to build these gels from caffeine molecules.
READ MORELonza Opens World’s Largest Dedicated Cell-and-Gene-Therapy Manufacturing Facility in Texas
NewsFirst-of-its-kind, state-of-the-art manufacturing facility with capacity to produce treatment for thousands of patients suffering from rare genetic disorders or life-threatening diseases.
READ MOREComments | 0 ADD COMMENT
To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free
LOGIN SUBSCRIBE FOR FREEWorld Congress on Advanced Biomaterials and Tissue Engineering
Jun 20 - Jun 21, 2018
Login
You must be logged in to post a comment.